Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why HEXO's Licensing Issue Isn't in the Same League as CannTrust's Fiasco


It could be tempting to lump all Canadian marijuana stocks together. This temptation could lead you to think that if there's a problem with one cannabis producer, it's affecting all of the others as well. Granted, in some cases that's true -- such as the retail environment constraints that are hurting the entire industry. But it's not always true.

For example, HEXO (NYSE: HEXO) reported on Nov. 15 that it had grown cannabis in an unlicensed area. At first glance, this could stir up concerns that HEXO is guilty of the same issues that have plagued CannTrust (NYSE: CTST) for months. But HEXO's licensing issues aren't even in the same league as CannTrust's problems and don't appear to be anything for investors to worry about.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments